Welcome!
IHH Healthcare (IHH)
Healthcare
IHH Healthcare says no wrongdoing found in Fortis investment
In its statement, IHH expressed its commitment to “stand firm” on Fortis’ side to “continue this growth journey”.
September 26, 2022
Broker's Calls
Broker's Digest: Parkway Life REIT, IHH Healthcare, Keppel Corporation, Yangzijiang Shipbuilding, Kimly
See what the analysts have to say this week.
September 15, 2022
Broker's Calls
IHH has 'plenty [of] opportunities to grow' despite termination of Ramsay Sime-Darby acquisition: CGS-CIMB
CGS-CIMB is keeping its 'add' call and target price of RM8.07 ($2.50) on IHH.
September 13, 2022
M&A
Discussions between IHH to acquire Ramsay Sime Darby Health Care Sdn Bhd have been terminated
IHH Healthcare, on March 22, announced that it has proposed to acquire 100% of Ramsay Sime Darby Health Care Sdn Bhd
September 09, 2022
Broker's Calls
Analysts optimistic on IHH Healthcare on further recovery in core businesses
IHH is currently trading at a very attractive FY22 EV/ebitda of 14x, close to -2 SD of its historical range.
August 30, 2022
Results
IHH Healthcare reports earnings of RM612 mil for 2QFY2022, up 27% y-o-y
Revenue for the period increased 2% y-o-y to RM4.37 billion on continued growth in key markets.
August 25, 2022
Broker's Calls
High inflation could benefit healthcare industry based on historical trends: DBS
DBS analyst Rachel Tan says the pricing power of healthcare service providers could offset the inflationary cost pressures.
August 18, 2022
Results
Parkway Life REIT reports DPU of 7.06 cents for 1HFY2022, assuages currency and rates exposure
The renewed lease for the Singapore hospital commences this month
August 08, 2022
Funds
IHH Healthcare, Sequoia India and EDBI part of investors in medtech start-up Us2.ai’s US$15 million series A round
This investment will enhance the delivery of care by doctors and speed up the diagnosis of heart conditions for the public:IHH CEO
April 14, 2022
Broker's Calls
Brokers' Digest: Econ Healthcare, IHH Healthcare, UOB, Food Empire, Netlink NBN Trust, Hyphens Pharma
See the analysts' recommendations and target prices here.
January 13, 2022